Home LiteratureArticle Details
PMID: 17325877 Published · ppublish English Comment Editorial Research Support, N.I.H., Extramural

p53 as a predictor for chemotherapy response in CLL cells.

Leukemia & lymphoma ·Vol. 48 ·No. 2 ·2007-02-00 ·Pages 219-20

Gandhi V

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/therapeutic use Apoptosis/drug effects Humans Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy,genetics Prognosis Tumor Suppressor Protein p53/genetics
Chemicals
Antineoplastic Agents Tumor Suppressor Protein p53
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Gandhi Varsha
Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. vgandhi@mdanderson.org
Article Info
Journal
Leukemia & lymphoma
Abbr.
Leuk Lymphoma
ISSN
1042-8194
DOI
10.1080/10428190601186028
Email
vgandhi@mdanderson.org
Published
2007-02-00
Pages
219-20
Language
English
Region
United States
NLM ID
9007422
Subset
IM
Grants
NCI NIH HHS · CA57629 · United States
NCI NIH HHS · CA81534 · United States
Corrections
CommentOn
PMID: 17325891
External Links
PubMed source DOI: 10.1080/10428190601186028 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2